CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251342877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Jun-Tao Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China. Hauptthemen laut MEDLINE: Breast Neoplasms, B7-H1 Antigen, Calcitonin Gene-Related Peptide, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Peripherally inserted central catheter (PICC)-related bloodstream infections (BSIs) are severe complications in breast cancer patients undergoing chemotherapy. This study evaluated the diagnostic potential of calcitonin gene-related peptide (CGRP), programmed cell death protein-1 (PD-1), and its ligand (PD-L1) as biomarkers for PICC-related BSIs.
Methods
A total of 384 breast cancer patients with PICC placement were retrospectively identified from medical records, of these, 78 developed BSIs and 306 did not. Serum levels of CGRP, PD-1, and PD-L1 were measured using enzyme-linked immunosorbent assay (ELISA) and quantitative polymerase chain reaction (qPCR), respectively, to evaluate their potential as diagnostic biomarkers for BSIs. Blood cultures were performed to confirm infections and identify pathogens.
Results
The BSIs group showed significantly lower CGRP and PD-L1 levels, and higher PD-1 expression and PD-1/PD-L1 ratios compared to the non-BSIs group (all P < 0.001). Receiver operating characteristic (ROC) curve analysis showed area under the curve (AUC) values of 0.84 for CGRP, 0.77 for PD-1, 0.70 for PD-L1, and 0.86 for the PD-1/PD-L1 ratio. Combined detection achieved an AUC of 0.96, with 88% sensitivity and 92% specificity. Gram-negative bacteria (59.8%) were the predominant pathogens, with Escherichia coli (29.3%) being the most common.
Conclusion
CGRP alone showed strong diagnostic utility, but combining CGRP, PD-1, and PD-L1 markedly enhanced accuracy. ELISA and qPCR detection of these markers provides results within hours, enabling earlier diagnosis than conventional blood cultures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China.
- Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital, Nanchang, China.
- Department of pediatrics, Nanchang People's Hospital, Nanchang, China.
- Department of General Surgery, Nanchang People's Hospital, Nanchang, China.
- Department of Endocrinology and Metabolism, Nanchang People's Hospital, Nanchang, China.
ORCID-Profile: Jun-Tao Tan, Ping-Hua Hu
Zitieren
APA
Tan, J. T., Hu, L., Jiang, Q. H., Hu, H., Yang, Z., Li, Z. H., & Hu, P. H. (2025). CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251342877
Vancouver
Tan JT, Hu L, Jiang QH, Hu H, Yang Z, Li ZH, et al. CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251342877
BibTeX
@article{Tan2025,
author = {Tan, Jun-Tao and Hu, Lili and Jiang, Qi-Hua and Hu, Hai and Yang, Zhi and Li, Zhi-Hua and Hu, Ping-Hua},
title = {CGRP, PD-1 and PD-L1 as Biomarkers for PICC-Related Bloodstream Infections in Breast Cancer Patients},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251342877}
}
EUVIMED